Possible nosocomial transmission of Pneumocystis jirovecii.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.Clinical microbiology reviews · 2018
   Review
2. Colonization of Pneumocystis jirovecii in Patients Who Received and not Received Corticosteroids Admitted to the Intensive Care Unit: Airborne Transmission Approach.Iranian journal of pathology · 2018
   Article
3. Added Value of Next-Generation Sequencing for Multilocus Sequence Typing Analysis of a Pneumocystis jirovecii Pneumonia Outbreak1.Emerging infectious diseases · 2017
   Article
4. [Research progress on genes mutations related to sulfa drug resistance inZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2017
   Review
5. EMC. Pediatria · 2017
   Review
6. Molecular Demonstration of a Pneumocystis Outbreak in Stem Cell Transplant Patients: Evidence for Transmission in the Daycare Center.Frontiers in microbiology · 2017
   Article
7. Pneumocystis jirovecii airborne transmission between critically ill patients and health care workers.Intensive care medicine · 2015
   Article
8. Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea.BMC infectious diseases · 2015
   Article
9. Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.Clinical medicine insights. Circulatory, respiratory and pulmonary medicine · 2015
   Review
10. Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections?BioMed research international · 2015
    Review
11. Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience.Wiener klinische Wochenschrift · 2014
    Article
12. Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.Current rheumatology reports · 2014
    Review
13. Update on opportunistic infections in the era of effective antiretroviral therapy.Infectious disease clinics of North America · 2014
    Review
14. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.Journal of clinical microbiology · 2014
    Article
15. Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.Rheumatology (Oxford, England) · 2012
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

8 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as